Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice
(Q47268225)
scientific article published in April 1999
scientific article published in April 1999
Language: